BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35269644)

  • 21. Allosteric modulation of β-arrestin-biased angiotensin II type 1 receptor signaling by membrane stretch.
    Tang W; Strachan RT; Lefkowitz RJ; Rockman HA
    J Biol Chem; 2014 Oct; 289(41):28271-83. PubMed ID: 25170081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced Bystander BRET (ebBRET) Biosensors as Biophysical Tools to Map the Signaling Profile of Neuropsychiatric Drugs Targeting GPCRs.
    Gaitonde SA; Bouvier M
    Methods Mol Biol; 2023; 2687():15-30. PubMed ID: 37464159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. β-Arrestin-2 BRET Biosensors Detect Different β-Arrestin-2 Conformations in Interaction with GPCRs.
    Oishi A; Dam J; Jockers R
    ACS Sens; 2020 Jan; 5(1):57-64. PubMed ID: 31849219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PLC-mediated PI(4,5)P2 hydrolysis regulates activation and inactivation of TRPC6/7 channels.
    Itsuki K; Imai Y; Hase H; Okamura Y; Inoue R; Mori MX
    J Gen Physiol; 2014 Feb; 143(2):183-201. PubMed ID: 24470487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detecting GPCR Signals With Optical Biosensors of Gα-GTP in Cell Lines and Primary Cell Cultures.
    Janicot R; Park JC; Garcia-Marcos M
    Curr Protoc; 2023 Jun; 3(6):e796. PubMed ID: 37310083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transient Receptor Potential Canonical 7 (TRPC7), a Calcium (Ca(2+)) Permeable Non-selective Cation Channel.
    Zhang X; Spinelli AM; Masiello T; Trebak M
    Adv Exp Med Biol; 2016; 898():251-64. PubMed ID: 27161232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid kinetic BRET measurements to monitor G protein activation by GPCR and non-GPCR proteins.
    Maziarz M; Garcia-Marcos M
    Methods Cell Biol; 2017; 142():145-157. PubMed ID: 28964333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged AT
    Hermosilla T; Encina M; Morales D; Moreno C; Conejeros C; Alfaro-Valdés HM; Lagos-Meza F; Simon F; Altier C; Varela D
    Sci Rep; 2017 Aug; 7(1):10131. PubMed ID: 28860469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canonical transient receptor potential TRPC7 can function as both a receptor- and store-operated channel in HEK-293 cells.
    Lièvremont JP; Bird GS; Putney JW
    Am J Physiol Cell Physiol; 2004 Dec; 287(6):C1709-16. PubMed ID: 15342342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transient receptor potential canonical 7: a diacylglycerol-activated non-selective cation channel.
    Zhang X; Trebak M
    Handb Exp Pharmacol; 2014; 222():189-204. PubMed ID: 24756707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct Conformational Dynamics of Three G Protein-Coupled Receptors Measured Using FlAsH-BRET Biosensors.
    Bourque K; Pétrin D; Sleno R; Devost D; Zhang A; Hébert TE
    Front Endocrinol (Lausanne); 2017; 8():61. PubMed ID: 28439254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A bioluminescence resonance energy transfer 2 (BRET2) assay for monitoring seven transmembrane receptor and insulin receptor crosstalk.
    Sanni SJ; Kulahin N; Jorgensen R; Lyngsø C; Gammeltoft S; Hansen JL
    J Recept Signal Transduct Res; 2017 Dec; 37(6):590-599. PubMed ID: 28854843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of β-Arrestin-Mediated G Protein-Coupled Receptor Ubiquitination Using BRET.
    Nagi K; Shenoy SK
    Methods Mol Biol; 2019; 1957():93-104. PubMed ID: 30919349
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BRET approaches to characterize dopamine and TAAR1 receptor pharmacology and signaling.
    Espinoza S; Masri B; Salahpour A; Gainetdinov RR
    Methods Mol Biol; 2013; 964():107-22. PubMed ID: 23296781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AT
    Bernhem K; Krishnan K; Bondar A; Brismar H; Aperia A; Scott L
    BMC Cardiovasc Disord; 2017 May; 17(1):126. PubMed ID: 28514967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRET-based effector membrane translocation assay monitors GPCR-promoted and endocytosis-mediated G
    Wright SC; Lukasheva V; Le Gouill C; Kobayashi H; Breton B; Mailhot-Larouche S; Blondel-Tepaz É; Antunes Vieira N; Costa-Neto C; Héroux M; Lambert NA; Parreiras-E-Silva LT; Bouvier M
    Proc Natl Acad Sci U S A; 2021 May; 118(20):. PubMed ID: 33990469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioluminescence in G Protein-Coupled Receptors Drug Screening Using Nanoluciferase and Halo-Tag Technology.
    Schihada H; Nemec K; Lohse MJ; Maiellaro I
    Methods Mol Biol; 2021; 2268():137-147. PubMed ID: 34085266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of BRET for studying G protein-coupled receptors.
    Kaczor AA; Makarska-Bialokoz M; Selent J; de la Fuente RA; Martí-Solano M; Castro M
    Mini Rev Med Chem; 2014 May; 14(5):411-25. PubMed ID: 24766382
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of angiotensin II-induced Ras activation in the trans-Golgi network and endoplasmic reticulum using bioluminescence resonance energy transfer-based biosensors.
    Balla A; Erdélyi LS; Soltész-Katona E; Balla T; Várnai P; Hunyady L
    J Biol Chem; 2011 Feb; 286(7):5319-27. PubMed ID: 21062747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioluminescence Resonance Energy Transfer (BRET) to Detect the Interactions Between Kappa Opioid Receptor and Nonvisual Arrestins.
    Bedini A
    Methods Mol Biol; 2021; 2201():45-58. PubMed ID: 32975788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.